SEE THE SCIENTIFIC STUDIES VALIDATING THE VIVI SCOREAPP
[1] Alchikh M, Conrad T, Obermeier P, Ma X, Schweiger B, Opota O, Rath B: Disease Burden and Inpatient Management of Children with Acute Respiratory Viral Infections during the Pre-COVID Era in Germany: A Cost-of-Illness Study. Viruses 2024; 16(4);
https://doi.org/10.3390/v16040507
https://pubmed.ncbi.nlm.nih.gov/38675850
[2] Alchikh M, Obermeier P, Schweiger B, Rath B: Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir. Pharmaceuticals 2023; 16(1);
https://doi.org/10.3390/ph16010085
https://pubmed.ncbi.nlm.nih.gov/36678583/
[3] Obermeier P, Heim A, Biere B, Hage E, Alchikh M, Conrad T, Schweiger B, Rath B: Linking digital surveillance and in-depth virology to study clinical patterns of viral respiratory infections in vulnerable patient populations. iScience 2022, 25(5)
https://doi.org/10.1016/j.cmi.2018.05.023
https://pubmed.ncbi.nlm.nih.gov/35573195
[4] Rath B, Seng S: Partnering for Enhanced Digital Surveillance of Influenza-like Disease and the Effect of Antivirals and Vaccines (PEDSIDEA) - First Results in the United States; Pediatrics 2020; 146;
https://doi.org/10.1542/peds.146.1MA1.29
[5] Rath B, Maltezou H, Papaevangelou V, Papagrigoriou‐Theodoridou M-A, Alchikh M, Myles P, Schweiger B, PEDSIDEA Network: Partnering for enhanced digital surveillance of influenza‐like disease and the effect of antivirals and vaccines (PEDSIDEA). Influenza and Other Respiratory Viruses 2019; 13(4)
https://doi.org/10.1111/irv.12645
https://pubmed.ncbi.nlm.nih.gov/31169347/
[6] Alchikh M, T. Conrad T, Hoppe C, Ma X, Broberg E, Penttinen P, Reiche J, Biere B, Schweiger B, Rath B: Are we missing respiratory viral infections in infants and children? Comparison of a hospital-based quality management system with standard of care. CMI 2019; 25(3)
https://doi.org/10.1016/j.cmi.2018.05.023
https://pubmed.ncbi.nlm.nih.gov/29906596/
[7] Rath B, Penttinen P: Incidence, Severity and Impact of Influenza. Eurosurveillance 2019; 24(23);
https://doi.org/10.2807/1560-7917.ES.2019.24.23.1900348
https://pubmed.ncbi.nlm.nih.gov/31186076/
[8] Ma X, Conrad T, Alchikh M, Reiche J, Schweiger B, Rath B: Can we distinguish respiratory viral infections based on clinical features? A prospective pediatric cohort compared to systematic literature review. Reviews in Medical Virology 2018; 28 (5) https://doi.org/10.1002/rmv.1997
https://pubmed.ncbi.nlm.nih.gov/30043515/
[9] Rath B, Conrad T, Myles P, Alchikh M, Ma X, Hoppe C, Tief F, Chen X, Obermeier P, Kisler B, Schweiger B: Influenza and other respiratory viruses: standardizing disease severity in surveillance and clinical trials. Expert Review of Anti-infective Therapy 2017; 15(6);
https://doi.org/10.1080/14787210.2017.1295847
https://pubmed.ncbi.nlm.nih.gov/28277820/
[10] Tief F, Hoppe C, Seeber L, Obermeier P, Chen X, Karsch K, Muehlhans S, Adamou E, Conrad T, Beresniak A, Schweiger B, Rath B: An Inception Cohort Study Assessing the Role of Pneumococcal and other Bacterial Pathogens in Children with Influenza and ILI and a Clinical Decision Model for Stringent Antibiotic Use. Antiviral Therapy 2016; 21(5). https://doi.org/10.3851/IMP3034
https://pubmed.ncbi.nlm.nih.gov/26867096/